The Immunobiogram, a novel in vitro diagnostic test to measure the pharmacodynamic response to immunosuppressive therapy in kidney transplant patients
Authors:
Open Access
- 9 September 2022
- journal article
- research article
- Published by Elsevier in Transplant Immunology
- Vol. 75, 101711
Abstract
No abstract availableKeywords
Funding Information
- HORIZON EUROPE Health
- European Commission (733248)
This publication has 21 references indexed in Scilit:
- Posttransplant peripheral blood donor–specific interferon-γ enzyme-linked immune spot assay differentiates risk of subclinical rejection and de novo donor-specific alloantibodies in kidney transplant recipientsKidney International, 2017
- Sirolimus and tacrolimus coefficient of variation is associated with rejection, donor-specific antibodies, and nonadherencePediatric Nephrology, 2016
- Barcelona Consensus on Biomarker-Based Immunosuppressive Drugs Management in Solid Organ TransplantationTherapeutic Drug Monitoring, 2016
- Rates and Determinants of Progression to Graft Failure in Kidney Allograft Recipients With De Novo Donor-Specific AntibodyAmerican Journal of Transplantation, 2015
- The kSORT Assay to Detect Renal Transplant Patients at High Risk for Acute Rejection: Results of the Multicenter AART StudyPLOS Medicine, 2014
- Clinical relevance of post-transplant pharmacodynamic analysis of cyclosporine in renal transplantationInternational Immunopharmacology, 2014
- Pretransplant Pharmacodynamic Analysis of Immunosuppressive Agents Using CFSE-Based T-Cell Proliferation AssayClinical Pharmacology & Therapeutics, 2009
- T-Cell Allorecognition and Transplant Rejection: A Summary and UpdateAmerican Journal of Transplantation, 2003
- Measurement of T-Lymphocyte Responses in Whole-Blood Cultures Using Newly Synthesized DNA and ATPClinical and Diagnostic Laboratory Immunology, 2000
- Lymphocyte Sensitivity to Cyclosporine and Tacrolimus in Chronic Renal Failure Patients and Clinical Significance in Renal TransplantationTransplantation Proceedings, 1998